Drug Shortage Report for TOBRAMYCIN INJECTION
Report ID | 162164 |
Drug Identification Number | 02230640 |
Brand name | TOBRAMYCIN INJECTION |
Common or Proper name | TOBRAMYCIN INJECTION |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | TOBRAMYCIN |
Strength(s) | 40MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
Packaging size | 30mL |
ATC code | J01GB |
ATC description | AMINOGLYCOSIDE ANTIBACTERIALS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2022-06-02 |
Estimated end date | 2023-03-31 |
Actual end date | 2023-03-31 |
Shortage status | Resolved |
Updated date | 2023-04-03 |
Company comments | On backorder effective September 1, 2022 until March 31, 2023. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v19 | 2023-04-03 | French | Compare |
v18 | 2023-04-03 | English | Compare |
v17 | 2023-02-24 | French | Compare |
v16 | 2023-02-24 | English | Compare |
v15 | 2022-12-15 | French | Compare |
v14 | 2022-12-15 | English | Compare |
v13 | 2022-12-04 | French | Compare |
v12 | 2022-12-04 | English | Compare |
v11 | 2022-08-24 | French | Compare |
v10 | 2022-08-24 | English | Compare |
v9 | 2022-08-24 | French | Compare |
v8 | 2022-08-24 | English | Compare |
v7 | 2022-08-08 | French | Compare |
v6 | 2022-08-08 | English | Compare |
v5 | 2022-08-04 | French | Compare |
v4 | 2022-08-04 | English | Compare |
v3 | 2022-06-08 | French | Compare |
v2 | 2022-06-08 | French | Compare |
v1 | 2022-06-08 | English | Compare |
Showing 1 to 19 of 19